multiple copies of the ankyrin repeat at their COOH terminals, and this repeat is required for binding to, and inhibition of, NF-B subunits. NF-B activation entails the signal-induced phosphorylation and degradation of IB molecules, which in turn releases NF-B to translocate into the nucleus and bind to response elements of target promoters (11, 19, 30, 42, 47, 53, 69) . The various NF-B subunits and IBs enable the cell to modulate NF-B responses in a highly controlled manner. For example, IBs are degraded at different rates, which can control the kinetics of an NF-B response (59). IBs also display certain stimuli-specific responses (59). The subunit composition of NF-B also influences gene activation. Only the p65, RelB, and c-Rel subunits have strong transcriptional activation domains. NF-B forms without one of these subunits (for example, p50 or p52 homodimers) are weaker transcription activators and can even function as repressors (5, 39, 40) . In summary, cells are able to modulate expression of NF-B-regulated genes by regulating the IBs expressed and the subunit composition of the NF-B activated (26) .
NF-B has been implicated in regulating cell proliferation and death in a number of cell types (6, 7, 29) . Intriguingly, NF-B has been found to both promote and suppress cell death. The role NF-B assumes in regulating cell death appears to depend on both cell type and apoptosis inducer (6, 7, 10, 12, 13, 34, 43, 56, 60, 63, 67) . In addition to regulating genes that directly influence cell proliferation and death, NF-B regulates expression of a number of cytokines and cell adhesion molecules operative in immune and inflammatory responses (2, 5, 17, 23, 38, 39, 68) . These molecules can also influence cell proliferation and death in a tissue. Understanding how NF-B regulates cell proliferation and death in an integrated, functioning tissue is therefore a major research challenge.
We are interested in better understanding the role of NF-B in regulating cellular proliferation and apoptosis of colonic epithelial cells. Colonic epithelium is a dynamic structure organized into invaginations known as the crypts of Lieberkü hn. These crypts open into the lumen of the intestinal tract. Located at the base of the crypt are a number of stem cells that divide continuously and are responsible for perpetual renewal of the epithelium (50) . As cells migrate up the crypt axis (due to the mitotic pressure from the cells below them), they stop dividing and differentiate. Differentiated cells continue their ascent toward the luminal surface, where they undergo anoikis or apoptosis (24, 25) . The lamina propria that underlies epithelial cells consists of connective tissue and a variety of wandering cells (lymphocytes, plasma cells, eosinophils, and mast cells), which can interact with epithelial cells. The regulation of cell turnover in the colon can therefore be influenced by signals generated by other cells in the tissue.
In this study, we investigated the expression and activity of NF-B in colonic epithelial cells. In addition, we determined the effect of the NF-B1 knockout on epithelial cell turnover in the mouse colon. Our results indicate that NF-B is active in epithelial cells under normal physiological conditions and that it participates in the regulation of epithelial cell turnover.
MATERIALS AND METHODS
Immunohistochemistry. Paraffin-embedded tissues were first deparaffinized by baking slides in a 60°C oven for 20 min. Slides were then treated with Hemo-De (Fisher Scientific, Pittsburgh, PA) before undergoing a series of ethanol immersions. To neutralize endogenous peroxidase activity, the sections were blocked for 20 min in 1% hydrogen peroxide in PBS. For the microwave antigen retrieval procedure, slides were immersed in 10 mM citrate buffer (pH 6.0) in a clean polyethylene chamber in a full-powered microwave for 10 min and were then cooled for 10-20 min. After washing three times with PBS-Brij solution, the sections were blocked in 10% normal horse or goat serum for 30-60 min to suppress nonspecific binding of IgG. Each tissue section was then incubated with primary antibody (anti-NF-B1 D-17, Santa Cruz Biotechnologies, Santa Cruz, CA; anti-p65 AB1604, Chemicon). The p65-nuclear localization signal (NLS) antibody that has been used to detect active p65 in human cells (MAB3026; originally available from Boehringer Mannheim and now sold by Chemicon) (52) could not be used for this analysis because it does not recognize mouse p65. Antibodies were incubated overnight at 4°C, except anti-p65, which was incubated for 1 h at room temperature. Slides were then washed three times with PBS-Brij and then incubated with anti-goat or anti-rabbit biotinylated secondary antibodies (Vector Laboratories, Burlingame, CA). For proliferating cell nuclear antigen (PNCA; clone-10; Signet) and bromodeoxyuridine (BrdU; Clone BU33; Sigma) staining, mouse primary antibodies were used with a Mouse-On-Mouse detection kit (Vector) to suppress nonspecific binding. Briefly, after citrate buffer retrieval, the tissues were incubated with blocking reagent for 1 h and washed twice with PBS for 2 min each. The sections were then incubated with Mouse-OnMouse diluent for 5 min before the primary antibody was applied. After 30 min of incubation with primary antibodies, tissues were washed with PBS and incubated with biotinylated anti-mouse IgG for 10 min. Incubation with ABC Reagent (Vectastain) was followed with three washes of PBSBrij, and then diaminobenzine reaction was applied. Slides were then counterstained with hematoxylin for 20 s and washed in graded ethanol and Histoclear. Finally, slides were mounted with coverslips and analyzed by light microscopy. Staining specificity for the NF-B antibodies was confirmed by comparing their staining with staining obtained using normal serum (Fig. 1C) . Competition experiments were also performed with specific peptide inhibitors that reduced the level of staining (data not shown).
Colonic epithelial cell isolation. The isolation of colonic epithelial cells was based on a procedure described by Homaidan et al. (33) . Distal colon was removed and washed three times with ϳ5 ml of washing buffer [150 mM NaCl and 1 mM freshly added dithiothreitol (DTT)] to remove adherent mucus. The colon was then placed in a 60-mm cell culture plate filled with ϳ5 ml of the dissociation buffer (130 mM NaCl, 1 mM Na 2 EDTA, 10 mM HEPES, 10% FCS, and 1 mM freshly added DTT, pH 7.4). The plate was placed on a shaker at 37°C and incubated for 15 min. Dissociated cells were collected into a 15-ml Falcon tube by removing the dissociation buffer from the colon. Incubation in dissociation buffer was repeated a total of six times. For the first and second collections, 1 mM EDTA was used, for the third and fourth, 5 mM was used, and for the final two, 10 mM EDTA was present. Isolated cells were processed immediately after isolation by centrifugation at 4°C (2,500 rpm) for 10 min. Proteins were extracted as described below.
Protein extraction. Following centrifugation of the isolated cells, the resulting pellet was washed twice with cold PBS. The cells were then lysed by incubating them at 4°C for 8 min with 500 l of buffer containing 0.1% NP-40 [10 mM HEPES-KOH, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 1 mM DTT, 2 mM MgCl 2 , 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 0.5 M sucrose, and 2 g/ml leupeptin] and transferred to Eppendorf tubes. The tubes were centrifuged at 4°C (14,000 rpm) for 10 min, and the resulting supernatant was collected into a new tube. This is the cytoplasmic extract. The resulting pellet was washed with 1 ml of the above buffer without NP-40, resuspended in 30 l of buffer (20 mM HEPES-KOH, pH 7.9, 1.5 mM MgCl 2 , 420 mM NaCl, 0.2 mM EDTA, 1 mM DTT, 5% glycerol, 0.5 mM PMSF, and 2 g/ml leupeptin) and then incubated for 40 min on ice. The nuclear suspension was centrifuged at 4°C (14,000 rpm) for 10 min. The resulting supernatant, the nuclear extract, was transferred to new tube and diluted with 45 l of a buffer (20 mM HEPES-KOH, pH 7.9, 50 mM KCl, 0.2 mM EDTA, 1 mM DTT, 20% glycerol, 0.5 mM PMSF, and 2 g/ml leupeptin). Protein concentrations of nuclear and cytoplasmic extracts were measured by the Bradford assay, and the tubes were placed in Ϫ80°C freezer for storage.
Immunoblotting. Thirty micrograms of proteins from each of the above-described samples were resolved on 12% SDSpolyacrylamide gel and transferred onto nitrocellulose membranes. Membranes were blocked for 1 h with 5% nonfat dry milk. Specific proteins were detected with the appropriate antibodies using enhanced chemiluminescence for detection (Santa Cruz). The antibodies used were p65 (1:1,000 C-19; Santa Cruz), p50/p105 (1:1,000 D-17; Santa Cruz), PCNA (1:500 clone-10; Signet), and alkaline phosphatase (1:500; Chemicon).
Electrophoretic mobility shift assay. Ten micrograms of nuclear extract, prepared as described in Protein extraction, in 10 l of buffer were mixed with 2 g poly-dIdC and 1 g BSA to a final volume of 19 l. After 15-min incubation on ice, 1 l of [␥-
32 P]ATP end-labeled double-stranded NF-B consensus oligonucleotide (TGAGGGGACTTTCCCAGGC) was added to each reaction and incubated at room temperature for an additional 15 min. The reaction products were separated on a 4% native polyacrylamide-0.5 ϫ Tris-borate-EDTA gel and analyzed by autoradiography. Supershift antibodies (1 l)
were included in the binding reaction as indicated (all supershift antibodies were obtained from Santa Cruz).
Animals. Six-week-old male NF-B1 knockout mice and their wild-type counterparts (B6/129P) were purchased from the Jackson Laboratory (Bar Harbor, ME) and housed in a controlled environment with a 12:12-h light/dark cycle. After an acclimation period of 4 wk, mice were killed and their colons were removed and processed for cell isolation or paraffin imbedding as described in Colonic epithelial cell isolation. For in vivo BrdU labeling, mice were injected intraperitoneally with BrdU (Zymed Laboratories, South San Francisco, CA) at a concentration of 50 mg/kg body wt. Two injections were performed, one at 24 h and the other at 12 h before death. Colons were then processed for immunohistochemistry. BrdU labeling was estimated by determining the fraction of cells with positively stained nuclei in each animal. Thirty crypts from the distal colon of each animal were arbitrarily chosen and examined. Only crypts cut longitudinally were considered in this analysis.
cDNA array analysis. The Clontech Atlas Mouse 1.2 cDNA array was used (Clontech, Palo Alto, CA). RNA was isolated from whole colon tissue immediately on removal following the Clontech protocol, with the exception that the Qiagen poly(A) mRNA isolation kit was used (Qiagen, Valencia, CA). cDNA labeling was performed using Clontech reagents, and the resulting probes were purified with a Centri-Spin column (Princeton Separations, Adelphia, NJ). Clontech membranes were probed and washed as described by Clontech, exposed to film, and then quantified with a Bio-Rad PhosphorImager (Bio-Rad, Hercules, CA). Autoradiograms were compared manually using a transparent alignment grid. Only hybridization signals that were precisely positioned in the array were considered further (a number of background "dots" appear on both arrays). True hybridization signals with apparent differences in intensity were then compared quantitatively on the PhosphorImager, with signal adjustments made using the housekeeping genes present at the bottom of the membrane. Nerve growth factor (NGF)-␣ expression found to be enhanced on the array was also analyzed by the RT-PCR assay, following a published protocol (64) . Primers for the NGF-␣ were CACCCTGCCCACTGAGGAGCCCAA and CCATCCATCTCTCCTGCACACA, which generated a 195-bp fragment from the NGF-␣ mRNA. (These primers spanned an intron, to prevent confusion with amplification products from trace amounts of genomic DNA in the reaction). Primers to hypoxanthine-guanine phosphoribosyltransferase, which were used as a control, have been previously described (64) .
RNase protection. Two NF-B-regulated genes not found on the Clontech cDNA array are TNF-␣ and Fas (3, 15) . To assay the expression levels of these genes, an RNase protection assay was performed using in vitro transcription plasmids obtained from PharMingen (San Diego, CA). RNA for this analysis was purified from whole mouse colon using TRIzol reagent (Life Technologies, Grand Island, NY). Complementary RNA labeling and RNase protection was performed as described by PharMingen. Resulting sequencing gels were exposed to film and quantified by PhosphorImager.
In situ hybridization. RNA probes for TNF-␣ in situ hybridization were transcribed in vitro from a pGEM-T Easy vector (Promega, Madison, WI). An RT-PCR-generated TNF-␣ gene fragment (ϩ292 to ϩ578 relative to the translation start site) was cloned into the pGEM-T Easy vector, and the orientation was determined by PCR using TNF-␣ primers and universal priming sites present in the plasmid. In vitro transcription of this clone with T7 RNA polymerase generated the antisense probe, whereas the Sp6 RNA transcription produced the sense probe. The sense and antisense RNA probes were labeled with psoralen-biotin using a BrightStar psoralen-biotin labeling kit according to the manufacturer's instructions (Ambion, Austin, TX). Hybridization was also performed according to the manufacturer's instructions. Briefly, 6-m sections were deparaffinized and rehydrated in nucleasefree alcohol. The tissue sections were treated with proteinase K, washed, prehybridized, and then probed with either the sense or antisense TNF-␣ probe in a humidifier chamber for 4 h at 55°C. After hybridization, sections were washed and incubated with a streptavidin-alkaline phosphatase conjugate. After several washes, signal was detected by nitroblue tetrazolium salt and 5-bromo-4-chloro-3-indol phosphate. Slides were dehydrated by gradual alcohol immersion, cleared by Histoclear, mounted with coverslips, and analyzed by light microscopy.
RESULTS

Immunohistochemical analysis of NF-B subunits in the mouse colon.
If NF-B is involved in regulating epithelial cell turnover, its expression and activity may change as epithelial cells mature. We therefore analyzed sections of mouse colon for the NF-B subunits p50 and p65. These two subunits were chosen for analysis because NF-B isolated from the colon has been found to be composed primarily of these subunits (see NF-B activity in epithelial cell isolates). As shown in Fig. 1A, p65 expression is concentrated at the bottom of the crypt where proliferating cells are present. Some of the staining is present in the nucleus, suggesting that a portion of the p65 may be active. It is not Figure 1B shows the immunohistochemical staining for NF-B1 proteins (p50 and p105). In contrast to the results obtained for p65, NF-B1 staining is more even through the length of the crypt, with more cytoplasmic staining present in cells closer to the luminal surface. Staining with normal serum shows some background at the top of the crypts, but is otherwise lower than that obtained with the NF-B antibodies (Fig.  1C) . Specific peptide inhibitors to these antibodies also indicates that the observed staining patterns are specific (data not shown). Immunoblot data described in Fig. 4 are also consistent with these staining patterns.
NF-B activity in epithelial cell isolates. To study the activity of NF-B in colonic epithelial cells, epithelial cells were nonenzymatically stripped from the mouse colon (33) . Sequential incubations in EDTA-containing buffers provided enriched populations of epithelial cells from different regions of the crypt. Three populations were isolated and characterized for markers of cell proliferation (PCNA) and differentiation (alkaline phosphatase). As shown in Fig. 2A , PCNA expression is highest in the last two isolated cell populations, whereas alkaline phosphatase is highest in the first isolated pool. These isolated cell populations were assayed for NF-B activity by the electrophoretic mobility shift assay (EMSA). As shown in Fig. 2B , NF-B activity is highest in proliferating cells. In addition, the size of the NF-B complex differs in the proliferating and mature cells, suggesting a change in subunit composition. To further characterize the NF-B from proliferating and mature cells, a supershift assay was performed. As shown in Fig. 3 , NF-B complexes isolated from proliferating cells include both the p65 and p50 subunits, whereas the mature cells have primarily p50 dimers (the low intensity of the p65 supershift may result from antibody destabilization of the protein-DNA complex). These results are consistent with the immunohistochemical analysis shown in Fig. 1 , in which proliferating cells displayed nuclear staining for p65 and the mature cells did not.
Protein extracts from isolated epithelial cells were also analyzed by immunoblotting (Fig. 4) . Consistent with the immunohistochemistry shown in Fig. 1 , the expression level of p65 is found to decrease as cells mature, whereas the levels of p50 and p105 are more even. The model that emerges is one in which the potent p65-p50 transcriptional activator is partially activated in proliferating cells of the crypt, with the activity and expression of p65 decreasing as cells mature.
NF-B activity in NF-B1 knockout mice.
To further explore the role of NF-B in regulating epithelial cell turnover, we analyzed colonic epithelium of NF-B1 knockout mice (55) . Unlike p65 knockout mice, NF-B1 knockout mice are viable, although they have a number of immunological alterations, including impaired immunoglobin isotype switching (10, 55 ). An EMSA analysis was performed using nuclear extracts prepared from colonic epithelial cells of NF-B1 knockout animals and their wild-type counterparts. As shown in Fig. 5 , the expected NF-B binding results were obtained from the wild-type isolates, with both p65-p50 and p50-p50 dimers present (isolated cell populations were combined for this assay). However, no NF-B binding activity was detected in the colonic epithelial cells of the NF-B1 knockout mice. The two faint complexes that are observed in the knockout animals cannot be supershifted with antibodies to any of the NF-B subunits. The NF-B1 knockout therefore significantly reduces NF-B activity in colonic epithelial cells and therefore provides a useful model for studying the role of NF-B in epithelial cell turnover in the colon.
Epithelial cell turnover NF-B1 knockout mice. To determine the effect of NF-B1 knockout on epithelial cell proliferation, colonic crypts were analyzed for length and expression of the PCNA. Figure 6 shows representative crypts from the distal colon of a wildtype (Fig. 6A ) and an NF-B1 knockout (Fig. 6B) animal. Figure 7 shows quantitative data of crypt length (in cell number) and proliferative zone (in cell number) averaged from three animals. As summarized in Fig. 7 , the average crypt length in wild-type animals is 22 cells in length, whereas the length of a crypt in the knockout tissue is ϳ31 cells. In addition, proliferating cells in the wild-type mice extend ϳ16 cells from the base of the crypt, whereas in the knockout animals the region of proliferation extends to ϳ25 cells from the crypt base. Also shown in Fig. 6 are the results from an in vivo BrdU labeling of colonic crypts from wild-type (Fig. 6C) and NF-B1 knockout mice (Fig. 6D) . The BrdU labeling results confirm the PCNA staining and show a cell labeling index ϳ2.3-fold higher in the knockout animal (BrdU labeling was estimated as described in MATERIALS AND METHODS). From these results, we conclude that NF-B1 plays a role in suppressing epithelial cell proliferation in the colon. Models for how NF-B1 may be performing this growth inhibitory role are discussed below.
We also analyzed apoptosis in the wild-type and knockout animals using the TUNEL assay (25) (data not shown). No significant differences could be detected between the two strains for apoptotic bodies. Our tentative conclusion is that there is no change in apoptosis rates in the NF-B1 knockout animal, although changes in the rates of cell shedding and phagocytosis can complicate interpretation of the TUNEL assay.
Gene expression profiling in NF-B1 knockout mice. To begin to address the mechanism by which the NF-B1 disruption leads to enhanced cell proliferation in the colon, gene expression profiling was performed. Two approaches were taken (using RNA isolated from the entire tissue). First, a Clontech Atlas mouse 1.2 cDNA array was probed (Fig. 8A) . Comparing the expression patterns on these arrays indicates that the expression of most genes remains unchanged in the NF-B1 knockout. One exception was NGF-␣, a subunit of NGF, which was found to be upregulated ϳ2.5-fold in the knockout. This result was confirmed by RT-PCR on an independent animal (Fig. 8B) . Second, two NF-B-regulated genes of interest that are not on the cDNA array (Fas and TNF-␣) were analyzed by an RNase protection assay (Fig. 8C) (3, 15) . In this assay, the NF-B1 knockouts were found express TNF-␣ at levels more than five times higher than their wild-type counterparts. Fas mRNA levels were similar in the wild-type and NF-B1 knockouts, indicating that altered expression of Fas is probably not contributing to the increased proliferation rate observed in the knockout mice. The increase in TNF-␣ expression was confirmed by RT-PCR on two other animals (data not shown). A number of cell types in the colon have been reported to express TNF-␣, including epithelial cells (45) . To determine whether epithelial cells were expressing TNF-␣ in the NF-B1 knockout, in situ hybridization was performed (Fig. 9) . The results from the in situ hybridization reveal that epithelial cells are at least partly responsible for the elevated levels of TNF-␣ in the NF-B1 knockout. The possible contribution of TNF-␣ and NGF-␣ to the observed proliferation changes in the knockout are discussed below.
DISCUSSION
The transcription factor NF-B participates in the regulation of cell proliferation and death in many cell types. Its participation in these events has been studied extensively in cell culture, where NF-B is typically found to promote cell proliferation and suppress apoptosis (6, 7, 10, 12, 13, 29, 34, 43, 56, 60, 63, 67) . However, its role in regulating cell turnover in tissue where a variety of cell types interact is less well understood. The complexity of NF-B function in an intact tissue is highlighted by the fact that NF-B is a positive regulator of a number of cytokines, which can have a profound influence on cell viability (2, 5, 17, 23, 38, 39, 68) .
Here we provide evidence that NF-B is active in normal mouse colonic epithelial cells. Similar results Fig. 8 . Differential gene expression analysis in wild-type and NF-B1 knockout mice. A: analysis of mRNA levels in wild-type and NF-B1 knockout mice by the Atlas mouse 1.2 cDNA array.
32 P-labeled cDNA probes were prepared from purified mRNA from wild-type or NF-B1 knockout mice. The probes were then hybridized to two separate Atlas mouse 1.2 array membranes. NGF, nerve growth factor; S29, 40S ribosomal protein S29; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. The housekeeping genes were used for normalization of signals. B: comparison of tumor necrosis factor (TNF)-␣ and Fas mRNA expression in wild-type and NF-B1 knockouts by the RNase protection assay. Total RNA was analyzed using the L32 and GAPDH mRNA signals as controls. C: RT-PCR analysis also shows enhanced NGF-␣ mRNA expression in NF-B1 knockouts. The hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene was amplified in parallel as a control. have been reported by others in both mouse and human tissue (although the level of NF-B activation increases in inflamed tissue) (49, 52) . Other groups have also reported expression of NF-B-regulated genes by normal colonic epithelial cells, suggesting a role for this transcription factor in tissue homeostasis (45) . Here we provide evidence that NF-B expression and activity change in mouse colonic epithelial cells as they mature. In particular, both the expression and the activity of the p65 subunit are lower in mature cells at the luminal surface. Interestingly, the inhibitor IB␤ is reciprocally expressed in colonic epithelium, being highly expressed in mature surface epithelial cells (66) .
Colonic epithelium therefore appears to be designed to have a low NF-B response at the surface. The changes in p65 and IB␤ expression during epithelial cell maturation also suggest that NF-B may participate in regulating epithelial cell turnover. The temporal and positional cues that are influencing p65 and IB␤ expression are not entirely clear but could include growth factor availability, extracellular matrix composition, or exposure to luminal contents such as short-chain fatty acids (9, 16, 44, 58) .
To study the influence of NF-B on cell turnover in the colon, we have analyzed NF-B1 knockout mice. It was found that disruption of the NF-B1 gene leads to a loss in NF-B activity in colonic epithelial cells and an increase in cell proliferation. In this regard, colonic epithelium appears to be similar to stratified skin epithelium, where NF-B has been found to play a growth inhibitory role (54) . We were unable to detect any differences in apoptosis in the NF-B1 knockout by the TUNEL assay. Apoptosis can, however, be difficult to analyze because apoptotic bodies may be rapidly eliminated from the tissue by phagocytosis and shedding. For these reasons it is premature to conclude that the rates of apoptosis have not been affected in the NF-B1 knockouts. The precise mechanism of NF-B in regulating cell proliferation in the colon may involve the activation and/or suppression of a battery of genes required in tissue maintenance.
By gene profiling, two genes were found to be increased in NF-B1 knockout animals, NGF-␣ and TNF-␣. Increased expression of these genes may be contributing to the enhanced cell proliferation in the colon of NF-B1 knockout mice. NGF-␣ is a component of the mouse NGF, and although it does not interact directly with cellular receptors, it is involved in the processing and stabilization of the receptor-binding NGF-␤ subunit (22) . NGF is produced by numerous cell types, including intestinal epithelial cells, and it can promote proliferation of epithelial cells under some conditions (18, 20, 61) . Modest TNF-␣ levels have also been found to enhance intestinal epithelial cell proliferation in cell culture systems, and it has been suggested to play a role in tissue repair (21, (35) (36) (37) . The enhanced TNF-␣ expression may also be partly responsible for the higher NGF-␣ expression (1, 46) . Further study will be required to determine the contribution of these proteins to the enhanced proliferation rates in NF-B1 knockout mice.
Given the central role of TNF-␣ in intestinal inflammation, the finding that this protein is upregulated in NF-B1 knockouts is particularly interesting (4, 37, 48, 65) . This finding is somewhat counterintuitive because the TNF-␣ promoter has a number of functional NF-B sites (3, 68) . A possible explanation for the higher TNF-␣ expression level in NF-B1 knockout mice comes from the finding that the p50 dimer (generated from the NF-B1 gene) can act as a potent transcriptional repressor of the TNF-␣ promoter through a highaffinity binding site specific for the p50 dimer (3). Whether mouse intestinal epithelial cells use the p50 dimer to suppress TNF-␣ expression remains to be determined. The finding that TNF-␣ can be produced in the NF-B1 knockout mice also implies that other transcription factors participate in the regulation of TNF-␣ expression in epithelial cells. A number of other response elements are present on the TNF-␣ promoter, and some of these response elements may be activated in the knockout (3, 68) .
In summary, our data show that NF-B is active and regulated in colonic epithelial cells and that activation of this transcription factor is associated with a suppression of proliferation. Whether NF-B plays a similar growth inhibitory role during different pathological situations is not clear. Changes in NF-B activity have also been implicated in carcinogenesis (8, 14, 51, 63) . In fact, the first NF-B subunit identified was v-Rel, an oncogene from the avian reticuloendotheliosis virus. The mechanism by which v-Rel transforms cells appears to involve the ability of v-Rel to enhance expression of a set of v-Rel-responsive genes and to interfere with the ability of other NF-B subunits to activate gene expression (62) . Other studies have revealed that activation of NF-B can enhance proliferation and reduce apoptosis in transformed cells (6, 28, 29, 31, 32, 41, 51, 63, 67) . Whether increased NF-B activity is a general facilitator of tumor growth in vivo is not clear. The influence of NF-B on tumor growth is likely to depend on a combination of effects, including the ability to promote cell survival and the ability to stimulate immune and inflammatory reactions to transformed cells.
